Explanipedia Public Learning Modules Vs Mis Dis Mal Information:
Description
Tesamorelin (INN; trade name Egrifta SV) is a synthetic form of growth-hormone-releasing hormone (GHRH) which is used in the treatment of HIV- associated lipodystrophy, approved initially in 2010. It is produced and developed by Theratechnologies, Inc. of Canada. The drug is a synthetic peptide consisting of all 44 amino acids of human GHRH with the addition of a trans -3-hexenoic acid group.
Tesamorelin News
Loading news…
Tags
No tags available for this topic.
